Recently, overexpression of MeCP2 have found in diverse types of cancers, including gastric cancer, endometrial cancers, and prostate cancer, whereas MeCP2 knockdown repressed the proliferation of tumor cells [35, 37, 38]. Here, MECP2 is linked to prostate carcinoma.